Desq Long
Sign in
SEC FORM 4
—

SAB Biotherapeutics, Inc. (SABS)

Disposition (code F) of 473 shares; price not stated (see filing).

Reporting Person Kropotova Alexandra · Officer Title CHIEF MEDICAL OFFICER · Transaction Code F

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001193125-26-395552 · filed 2026-09-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "SAB Biotherapeutics, Inc. (SABS)." Disclosed 2026-09-18. https://desqlong.com/cards/0001193125-26-395552-1 (retrieved 2026-09-26).